KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Total Liabilities (2016 - 2026)

Encompass Health (EHC) has disclosed Total Liabilities for 18 consecutive years, with $3.9 billion as the latest value for Q1 2026.

  • For Q1 2026, Total Liabilities rose 6.54% year-over-year to $3.9 billion; the TTM value through Mar 2026 reached $3.9 billion, up 6.54%, while the annual FY2025 figure was $3.8 billion, 3.48% up from the prior year.
  • Total Liabilities hit $3.9 billion in Q1 2026 for Encompass Health, up from $3.8 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $4.5 billion in Q2 2022 and bottomed at $3.7 billion in Q3 2025.
  • Average Total Liabilities over 5 years is $3.9 billion, with a median of $3.8 billion recorded in 2023.
  • Year-over-year, Total Liabilities dropped 16.17% in 2023 and then grew 6.54% in 2026.
  • Encompass Health's Total Liabilities stood at $3.8 billion in 2022, then grew by 0.81% to $3.8 billion in 2023, then decreased by 3.15% to $3.7 billion in 2024, then grew by 3.48% to $3.8 billion in 2025, then rose by 3.46% to $3.9 billion in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $3.9 billion, $3.8 billion, and $3.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.